A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions

@article{Etwel2008ASM,
  title={A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions},
  author={Fatma Etwel and Michael J Rieder and John Richard Bend and Gideon Koren},
  journal={Drug Safety},
  year={2008},
  volume={31},
  pages={169-180}
}
AbstractBackground: Pemoline is a CNS stimulant that was introduced in 1975 in the US and was used to treat children with attention deficit hyperactivity disorder. Pemoline was withdrawn from the market 30 years later because of fatal hepatotoxicity associated with its use. Objective: To create a system that will estimate the potential association between a serious adverse event and a medication early in its marketing cycle. Method: All case reports of acute liver failure associated with… 

Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.

Drug-induced liver injury: what was new in 2008?

TLDR
As in past years, 2008 was replete with publications dealing with virtually all facets of DILI, including updated incidence and prevalence data, as well as the latest information regarding mechanisms of liver injury.

Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.

  • Lucila I. Castro-PastranaB. Carleton
  • Medicine
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique
  • 2011
TLDR
Five strategic elements that should be included in pharmacovigilance initiatives in pediatrics are presented and the importance of an efficient translation of the pharmacov Vigilance knowledge into clinical practice to achieve safer drug therapy in children is discussed.

Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments

  • M. Rieder
  • Medicine
    Journal of clinical pharmacology
  • 2018
TLDR
Clinicians as well as drug regulatory agencies and industry need to be both vigilant and astute aswell as aware that ADRs in children are often different in nature and frequency from those in adults.

Improving the Reporting of Adverse Drug Reactions in the Hospital Setting

TLDR
The present system for addressing adverse events, obstacles to reporting them, and the important role any hospital physician could play in reporting adverse events and potential adverse drug reactions are described.

Safety assessment in pediatric studies.

TLDR
In this chapter, several novel methods, both clinically based pharmacoepidemiological approaches and laboratory-based methods, are described to identify associations of a drug with a rare, serious adverse reaction.

Evaluating risk detection methods to uncover ontogenic-mediated adverse drug effect mechanisms in children

TLDR
This study underscores the opportunity for using population modeling techniques, which leverage drug event reporting across development stages, as biologically-inspired detection methods for evaluating ontogenic mechanisms in pediatric drug safety.

Eosinophilic Hepatitis in an Adolescent During Lisdexamfetamine Dimesylate Treatment for ADHD

TLDR
The case of an adolescent who developed eosinophilic hepatitis during treatment for attention-deficit/hyperactivity disorder with lisdexamfetamine dimesylate (Vyvanse) is described, believed to be the first report of hepatic injury attributed to lisdExam Fetamine dinesylate.

Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist

The subject of drug-induced liver injury (DILI) has been evolving for decades. While various guidance and other documents have been produced to help identify and manage DILI in the clinical trial

Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring

TLDR
Clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring for major psychotropic drug classes and establish the efficacy and safety of drugs currently being used off-label in the pediatric population.

References

SHOWING 1-10 OF 35 REFERENCES

Pemoline hepatotoxicity and postmarketing surveillance.

TLDR
Limitations in postmarketing surveillance and public reporting in the United States, particularly in the 1980s, largely accounted for delays in an appropriate response to pemoline hepatotoxicity.

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

TLDR
The incidence of serious and fatal adverse drug reactions in US hospitals was found to be extremely high, and data suggest that ADRs represent an important clinical issue.

Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.

TLDR
Four cases of marked liver dysfunction in children on pemoline were encountered, two of these progressed to fulminant hepatic failure requiring liver transplantation and in those cases where autoantibodies were measured, there was evidence for autoimmune activation.

Hepatotoxicity due to pemoline (Cylert): a report of two cases.

TLDR
A spectrum of hepatic disease due to pemoline is considered and the importance of obtaining aminotransferase values before, during initiation, and throughout treatment is stressed.

Pemoline Therapy Resulting in Liver Transplantation

TLDR
With increasing evidence linking pemoline to liver failure, this agent should not be considered first-line therapy for ADHD and parents and patients should be educated on the signs and symptoms of liver toxicity.

A study of compliance with FDA recommendations for pemoline (Cylert).

TLDR
Compliance with product labeling recommendations to use pemoline as second-line therapy for attention-deficit/hyperactivity disorder (ADHD) and to obtain baseline and biweekly liver enzyme tests was low for both recommendations.

Adverse drug reactions

An adverse drug reaction is any undesirable effect of a drug beyond its anticipated therapeutic effects occurring during clinical use. In contrast, an adverse drug event is an untoward occurrence

A method for estimating the probability of adverse drug reactions

TLDR
It was shown that the ADR probability scale has consensual, content, and concurrent validity and may be applicable to postmarketing drug surveillance.

Case-Population Studies in Pharmacoepidemiology

TLDR
Most of the studies reviewed suffer from incomplete case ascertainment, inaccurate definition of the disease of interest, incomplete information on exposures and other risk factors, and/or limited control of potential confounding, among other limitations.